Saluda Medical, Inc. (ASX:SLD)

Australia · Delayed Price · Currency is AUD

0.2450

0.00 (0.00%)

Oct 30, 2026, 4:11 PM AEDT

Saluda Medical Financials Overview

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Revenue	90.18	90.18	70.36	51.68	22.23
Revenue Growth	18.55%	28.17%	36.13%	132.45%	-
Gross Profit	44.08	44.08	32.76	23.11	4.04
Operating Income	-144.49	-144.49	-118.05	-99.14	-92.22
Net Income	-239.61	-239.61	-149.3	-97.83	-92.16
Earnings Per Share	-1.48	-1.48	-45.92	-30.13	-28.40
EPS Growth	-	-	-	-	-

Revenue by Geography

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
United States	63.23	63.23	49.88	32.9	6.48
Australia	6.65	6.65	5.29	7.05	4.72
Germany	9.76	9.76	5.36	4.17	3.48
Netherlands	3.38	3.38	3.94	2.84	3.49
United Kingdom	3.63	3.63	3	2.58	3.13
Other Foreign Countries	3.53	3.53	2.89	2.15	0.94
Total	90.18	90.18	70.36	51.68	22.23

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Cash & Investments	116.38	116.38	54.5	71.79	166.74
Total Debt	99.75	99.75	205.12	71.79	67.39
Net Cash (Debt)	16.63	16.63	-150.62	0.01	99.35
Net Cash Growth	-78.22%	-	-	-99.99%	-
Net Cash Per Share	0.10	0.10	-46.32	0.00	30.62

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Operating Cash Flow	-115.98	-115.98	-118.24	-93.32	-85.66
Capital Expenditures	-0.74	-0.74	-1.27	-1.08	-2.37
Free Cash Flow	-116.72	-116.72	-119.51	-94.4	-88.03
Free Cash Flow Growth	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
Gross Margin	48.89%	48.89%	46.56%	44.72%	18.17%
Operating Margin	-160.24%	-160.24%	-167.79%	-191.82%	-414.78%
Pretax Margin	-165.09%	-165.09%	-211.46%	-188.76%	-411.76%
Profit Margin	-265.72%	-265.72%	-212.21%	-189.29%	-414.52%
FCF Margin	-129.44%	-129.44%	-169.87%	-182.66%	-395.93%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023
Period Ending	Nov '26 Nov 2, 2026	Jun '26 Jun 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023
PS Ratio	0.47	0.89	-	-	-